SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-143338
Filing Date
2021-11-24
Accepted
2021-11-24 09:18:04
Documents
14
Period of Report
2021-11-24
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2129361d14_8k.htm   iXBRL 8-K 47235
2 EXHIBIT 3.1 tm2129361d14_ex3-1.htm EX-3.1 11486
3 EXHIBIT 3.2 tm2129361d14_ex3-2.htm EX-3.2 131807
  Complete submission text file 0001104659-21-143338.txt   401488

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adms-20211124.xsd EX-101.SCH 3037
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adms-20211124_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adms-20211124_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2129361d14_8k_htm.xml XML 3724
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 211441426
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences